FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Clinical Trials, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06244004
Phase: PHASE2
Trial Summary: This phase II trial compares the effect of FDG-positron emission tomography (PET)-guided metastasis directed radiation therapy (MDRT) in combination with standard treatments to standard treatments alo – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): Northwestern University
Acronym:

Pin It on Pinterest